Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.23 – $0.64
21% from low
Exchange
OTC Link
OS
Borrow rate
8.41%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $41.0K | $27.0K | $0 | $0 | $34.9K | $50.4K | $0 | $54.7K |
| Gross profit | −$41.0K | −$27.0K | $0 | $0 | −$34.9K | −$50.4K | $0 | −$54.7K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $93.8K | $605.7K | $2.7M | $4.8M | $2.3M | $1.1M | $651.2K | $56.3K |
| Operating income | −$899.0K | −$1.8M | −$9.4M | −$9.8M | −$6.1M | −$5.0M | −$2.3M | −$1.7M |
| EBITDA | −$858.0K | −$1.8M | −$8.4M | −$8.1M | −$5.7M | −$5.0M | −$2.3M | −$1.9M |
| Net income | −$938.0K | −$1.9M | −$8.5M | −$7.7M | −$6.1M | −$6.8M | −$503.0K | −$1.7M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -8.30 | -10.60 | -24.20 | -12.40 | -8.70 | -4.50 | -0.25 | -0.58 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2M | $-2.54 | $-2.54–$-2.54 | 1 |
| 2027 | $63M | $6.93 | $6.93–$6.93 | 1 |
Forward consensus · source: Financial Modeling Prep
GREY MATTERS HEALTH INC
No one on the platform currently holds AGNPF.
No tracked institution reports a position in AGNPF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-04-21 | 1-for-10reverse |
| 2023-03-03 | 4-for-1 |
| 2021-11-24 | 1-for-100reverse |
No one on the platform has traded AGNPF yet.
| $2M |
| — |
| IBOGFUniversal Ibogaine Inc. | $0.03 | +11.58% | $9M | — |
| IBXXFImagion Biosystems Limited | $0.03 | +0.00% | $7M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Grey Matters Health Inc. Advances US Alzheimer's Clinics https://ow.ly/ZxY650Zgy0N Grey Matters Health Inc. closes CA$1.25M financing to launch brain-specific PET clinics targeting the expanding Alzheimer's diagnostics market and early detection demand. $GREY.CN $AGNPF
View on StockTwits ↗Alzheimer's Imaging Push Gains Fresh Funding as U.S. Clinic Plans Move Forward https://ow.ly/LHub50ZglXR Grey Matters Health Inc. ( $GREY.CN $AGNPF ) closed an expanded US$1.25 million private placement and said proceeds will support its Alzheimer's disease program and planned first U.S. brain-specific neuroimaging clinic.
View on StockTwits ↗Grey Matters Health Positions for Growth in Expanding Alzheimer's Diagnostics Market https://ow.ly/In5w50Zaawh Grey Matters Health advances its Alzheimer's neuroimaging strategy with fresh financing and plans for the first U.S. brain-specific PET clinic, capitalizing on rising demand for early detection tools. $GREY.CN $AGNPF
View on StockTwits ↗Alzheimer's Diagnostic Clinic Initiative Moves Forward After Financing Close https://ow.ly/wVZN50Z9H2r Grey Matters Health Inc. ( $GREY.CN $AGNPF ) closed the first CA$500,000 tranche of a financing that the company said will support its Alzheimer's disease program and planned U.S. brain-specific neuroimaging clinic.
View on StockTwits ↗New Alzheimer's Imaging Push Expands as Financing Terms Get Investor-Friendly https://ow.ly/mHpo50Z5I24 Grey Matters Health Inc. ( $GREY.CN $AGNPF ) amended warrant terms tied to its CA$1 million private placement as it advances plans for a U.S. brain-specific neuroimaging clinic focused on Alzheimer's diagnostics.
View on StockTwits ↗200 Brain PET Scans, 162 Alzheimer's Drugs: A Diagnostic Push Takes Shape https://ow.ly/i5Hs50Z3gK4 Grey Matters Health Inc. ( $GREY.CN $AGNPF ) signed an LOI tied to a minimum of 200 brain PET scans for an Alzheimer's clinical trial while expanding its NovaScan neuroimaging strategy.
View on StockTwits ↗$AGNPF https://smallcappower.com/top-stories/grey-matters-health-cse-grey-targeting-a-rapidly-expanding-neuroimaging-opportunity/
View on StockTwits ↗Name Change, Share Consolidation, and US Clinic Strategy Signal Shift Toward Alzheimer's Diagnostics https://ow.ly/L2Zj50YEBwQ Algernon Health ( $AGN.CN $AGNPF ) plans to rebrand to Grey Matters Health Inc. while advancing its Alzheimer's diagnostic strategy and U.S. clinic rollout.
View on StockTwits ↗First US Brain-Only PET Clinic Targets Alzheimer's Detection as Diagnostic Demand Expands https://ow.ly/pgiM50YzTfi Algernon Health ( $AGN.CN $AGNPF ) is opening its inaugural brain PET clinic in Florida with a five-year lease and renewal option.
View on StockTwits ↗America's First Brain-Dedicated PET Scanning Clinics: A Turnaround Play for Chart-Savvy Investors? https://ow.ly/6g3h50YzjhR Technical Analyst Stewart Thomson explains why he thinks Algernon Health ( $AGN.CN $AGNPF ) is a Strong Speculative Buy.
View on StockTwits ↗Healthcare Firm Targets Alzheimer's With Technology Breakthrough https://ow.ly/pzjQ50WS8Fx Healthcare company Algernon Health rebrands and unveils plan to open brain-specific PET scanning clinics in North America to meet rising demand for Alzheimer's diagnostics. Read more to learn how this shift positions the company at the center of a growing medical need. $AGN.CN $AGNPF
View on StockTwits ↗Biotech Firm Adjusts Placement Terms to Fuel U.S. Expansion https://ow.ly/owWk50Wm1Mz Canadian healthcare and clinical stage drug development company Algernon Pharmaceuticals Inc. updates the pricing and warrant terms for its previously announced non-brokered private placement. Read why one technical analyst thinks the stock is ready to break out. $AGN.CN $AGNPF
View on StockTwits ↗Biotech Firm Gains Exclusive Alzheimer's Rights in U.S. and Canada https://ow.ly/qp4e50W1Ptk Algernon Pharmaceuticals Inc. secures exclusive Alzheimer's clinic rights in Canada and key U.S. cities, positioning for a high-growth breakthrough. Learn how Algernon plans to launch cutting-edge clinics featuring PET scan technology and expand into a multibillion-dollar diagnostics market $AGN.CN $AGNPF
View on StockTwits ↗Co. Poised to Begin Major New Bull Market: https://ow.ly/VjZB50VY19H Technical Analyst Clive Maund explains why he thinks Algernon Pharmaceuticals Inc. is an Immediate Strong Buy. $AGN.CN $AGNPF
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.